X4 Pharma
3 known investors
X4 Pharmaceuticals develops medicines for people living with rare immune disorders, including treatments for chronic neutropenia. The company focuses on advancing therapeutic solutions in the rare disease space.
3 known investors
X4 Pharmaceuticals develops medicines for people living with rare immune disorders, including treatments for chronic neutropenia. The company focuses on advancing therapeutic solutions in the rare disease space.